Get up to 90% off - Urjas Oil X
Emletra Junior is a prescription medicine that is available as a Tablet. Emletra Junior also has some secondary and off-label uses. These are listed below.
The correct dosage of Emletra Junior depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Emletra Junior include Headache. Besides the aforementioned side effects, there are other adverse effects of Emletra Junior as well, which are listed below. Such side effects of Emletra Junior normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Emletra Junior has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Emletra Junior's effects on the liver, heart and kidney are discussed below in the Emletra Junior related warnings section.
Emletra Junior is contraindicated in people with pre-existing medical conditions like Liver Disease, Hemophilia as it can result in adverse effects. Other contraindications of Emletra Junior have been discussed in the sections ahead.
Drug interactions for Emletra Junior have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Emletra Junior is considered not safe while driving, and is not addictive.
Emletra Junior is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Emletra Junior is used -
Severe
Moderate
Mild
Common
Is the use of Emletra Junior safe for pregnant women?
Emletra Junior can have harmful effects in pregnant women. If you experience any discomfort after using Emletra Junior, then discontinue the use and take your doctor's advice.
Is the use of Emletra Junior safe during breastfeeding?
Emletra Junior may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Emletra Junior, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Emletra Junior.
What is the effect of Emletra Junior on the Kidneys?
Using Emletra Junior does not have any harmful effects on kidneys.
What is the effect of Emletra Junior on the Liver?
Emletra Junior is rarely harmful for the liver.
What is the effect of Emletra Junior on the Heart?
Side effects of Emletra Junior rarely affect the heart.
Emletra Junior should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Emletra Junior unless your doctor advises you to do so -
Is this Emletra Junior habit forming or addictive?
Emletra Junior is not addictive in nature.
Interaction between Food and Emletra Junior
Some foods when eaten with Emletra Junior can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Emletra Junior
Taking alcohol with Emletra Junior can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811